The incidence of adverse reactions listed below was determined as follows: very often -> 10%; often -> 1%, but <10%; infrequently -> 0.1%, but less than 1%; rarely -> 0.01%, but less than 0.1%; very rarely - less than 0.01%, including individual reports; frequency is unknown (can not be calculated from available data).
From the side of water-electrolyte and acid-base state:
Often: disturbances of the water-electrolyte balance, including those that occur with clinical symptoms. Symptoms that indicate the development of violations of water-electrolyte balance may be headache, convulsions, tetany, muscle weakness, heart rhythm disorders and dyspeptic disorders.These disorders can develop either gradually (for a long time) or quickly (for a very short time, for example, in the case of high doses of furosemide in patients with normal renal function). Factors contributing to the development of violations of water-electrolyte balance are the main diseases (for example, cirrhosis of the liver or heart failure); concomitant therapy with drugs that change the water-electrolyte balance; malnutrition and drinking regimen; vomiting, diarrhea, increased sweating. Dehydration and hypovolemia (decrease in the volume of circulating blood), especially in elderly patients, which can lead to hemoconcentration with a tendency to develop thrombosis (see below). Increase in the concentration of creatinine in the blood. Increase in the concentration of triglycerides in the blood serum.
Often: hyponatremia, hypochloraemia, hypokalemia, increased concentration cholesterol in the blood. Increased concentration of uric acid in the blood and exacerbation of the gout.
Infrequently: decreased glucose tolerance. A manifestation is possible
latent-flowing diabetes mellitus.
Frequency unknown: hypocalcemia, hypomagnesemia, increased concentration urea in the blood, metabolic alkalosis.
From the cardiovascular system:
Often: a marked decrease in blood pressure, including orthostatic hypotension;
Rarely: vasculitis;
Frequency unknown: thrombosis.
From the side of the kidneys and urinary system:
Often: increased urine volume;
Rarely: tubulointerstitial nephritis;
Frequency unknown: increased urinary sodium, increased urinary chloride, urinary retention (in patients with partial obstruction of the urinary tract, see section "Special instructions"), nephrocalcinosis / nephrolithiasis in premature infants (see section "Special instructions"), renal insufficiency see section "Interaction with other drugs").
From the digestive system:
Infrequently: nausea;
Rarely: vomiting, diarrhea;
Rarely: acute pancreatitis.
From the liver and bile ducts:
Rarely: cholestasis, increased activity of "liver" transaminases.
From the nervous system:
Often: hepatic encephalopathy in patients with hepatocellular insufficiency (cf.section "Contraindications"),
Rarely: paresthesia.
From the organ of hearing:
Infrequently: hearing impairment, although usually transient, especially in patients with renal insufficiency, hypoproteinemia (eg, with nephrotic syndrome) and / or too fast intravenous administration of furosemide;
Rarely: noise in ears.
From the skin:
Infrequently: pruritus, urticaria, rash, bullous dermatitis, erythema multiforme, pemphigoid, exfoliative dermatitis, purpura, photosensitivity reactions;
Frequency unknown: Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis and drug rash with eosinophilia and systemic symptoms (DRESS-syndrome).
From the immune system:
Rarely: severe anaphylactic or anaphylactoid reactions up to the development of anaphylactic shock.
On the part of the blood system:
Often: hemoconcentration;
Infrequently: thrombocytopenia;
Rarely: leukopenia, eosinophilia;
Rarely: agranulocytosis, aplastic anemia, or hemolytic anemia.
Congenital, hereditary and genetic disorders:
Frequency unknown: increased risk of non-invasion of the arterial duct, when furosemide is introduced to premature infants during the first week of life.
General violations and violations at the place of introduction:
Rarely: fever;
Frequency unknown: after intramuscular injection, a local reaction in the form of pain is possible.
Since some adverse reactions (such as a change in the blood picture, severe anaphylactic or anaphylactic reactions, severe skin allergic reactions) may, under certain conditions, threaten the life of the patient, then any side effects should immediately be reported to the doctor.